Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Solid Data Carry U.S. Markets Higher

Published 06/18/2013, 04:30 PM
Updated 07/09/2023, 06:31 AM

U.S. stocks closed higher Tuesday, rising for a second day in a row as traders wait for signs Wednesday from the U.S. Federal Reserve on the state of the U.S. economy and the status of its ongoing stimulus programs. Tuesday's gains also were supported by positive housing data, which despite narrowly trailing expert opinion, still showed permit applications for single-family homes rising to a seven-year high. A separate report showed inflation remains in check. All 10 sectors in the S&P 500 were higher, led by shares of industrial and consumer discretionary companies. The weakest gains were among mining and materials stocks following declines for most metals in commodities trade.

The policy-setting Federal Open Market Committee began a two-day meeting Tuesday and it is widely expected to leave its bond-buying stimulus program unchanged. More important -- at least for traders -- will be the language in the FOMC statement Wednesday and comments by Fed Chairman Ben Bernanke during a 2 p.m. news conference, all of which will be scrutinized for any clues as to when the central will begin to taper back its $85-billion-a-month bond-buying program.

U.S. Housing Starts
Economic data was largely supportive of stocks. Housing starts climbed 6.8% during May to a 914,000 annualized rate, the Commerce Department reported. That trailed the median estimate of experts polled by Bloomberg News looking for housing starts to climb to a 950,000 annualized pace. The federal agency also revised its headline number for April to a 856,000 annualized pace while saying applications to build one-family homes rose 1.3% to a 622,000 pace during May - the fastest rate since May 2008.

Also Tuesday, the Labor Department said the consumer price index edged 0.1% higher last month after two straight months of declines. The so-called core index - which excludes food and energy costs and is closely watched by Fed officials because it more accurately maps price trends - rose 0.2% last month and is up 1.7% over the past 12 months.

Commodities were mixed. Gold for August delivery slid $16.20 to settle at $1,366.60 per ounce while July silver was down 8 cents to finish at $21.68 per ounce. July copper fell 4.5 cents to settle at $3.16 per pound. Among hydrocarbons, July crude oil rose 67 cents to settle at $98.44 per barrel while July natural gas added 3 cents and finished at $3.91 per 1 mln BTU.

Here's Where The U.S. Markets Stood At Day's End

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • S&P 500 up 12.39 at 1651.43
  • Nasdaq Composite up 29.7 to 3481.82
  • Dow Jones Industrial Average up 138.38 to 15318.23
GLOBAL SENTIMENT
  • Hang Seng Index unchanged
  • Shanghai China Composite Index up 0.14%
  • FTSE 100 Index up 0.69%
UPSIDE MOVERS
  • (+) WLT up 16.5% regular hours, Morgan stanley Tuesday reiterates its Overweight rating for the stock and set a $47 a share price target -- suggesting as much as a threefold increase in its stock price.
  • (+) CBMX up 14.5% regular hours, Said prenatal testing has shown a "significant uptick" during the six months since data from two National Institutes of Health studies showing the value of chromosomal microarray analysis was published.
  • (+) GEVO up 20% regular hours, Resumes commercial production of isobutanol at its plant in southwestern Minnesota.
DOWNSIDE MOVERS
  • (-) GNMK down 12% regular hours, Reduces projected FY13 revenue by $5 mln from its previous guidance, now expecting around $30 mln in yearly revenue. Analysts, on average, have been looking for around $35 mln in revenue this year by the molecular diagnostics company.
  • (-) HRL down 3.5% regular hours, Lowers FY13 EPS guidance to $1.88 to $1.96 per share, down $0.07 per share from its prior guidance.
  • (-) MNKD down 12% regular, CFO says the firm has considered waiting to partner with another firm until regulators sign off on Afrezza diabetes drug.
After Hours Stock News From Midnight Trader

.

Copyright © 2013 MT Newswires, a Division of MidnightTrader, Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.